Imagine being a patient whose infusion therapy to treat Crohn’s disease cost $40,000, but who later found the same treatment for $4,000 at a treatment center a few miles down the road.
On top of that, the patient also gets paid $500 in shared-savings cash every time he or she drives to the new location for treatment.
What seems too good to be true is now the reality for some public employees with medical price transparency. And it may become a common reality for almost everyone else, thanks to a new finalized federal rule released by the Centers for Medicare and Medicaid Services.
There’s bipartisan agreement that patients deserve genuine price transparency when it comes to the cost of medical procedures and health care services.